FR2882265B1 - Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. - Google Patents
Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2.Info
- Publication number
- FR2882265B1 FR2882265B1 FR0505228A FR0505228A FR2882265B1 FR 2882265 B1 FR2882265 B1 FR 2882265B1 FR 0505228 A FR0505228 A FR 0505228A FR 0505228 A FR0505228 A FR 0505228A FR 2882265 B1 FR2882265 B1 FR 2882265B1
- Authority
- FR
- France
- Prior art keywords
- diabetes
- prevention
- preparation
- treatment
- type
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Emergency Medicine (AREA)
- Ophthalmology & Optometry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Priority Applications (20)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0505228A FR2882265B1 (fr) | 2005-02-21 | 2005-05-23 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. |
MX2007009996A MX2007009996A (es) | 2005-02-21 | 2006-02-20 | Utilizacion de rimonabant para la preparacion de medicamentos utiles en la prevencion y el tratamiento de la diabetes de tipo 2. |
BRPI0608183-5A BRPI0608183A2 (pt) | 2005-02-21 | 2006-02-20 | utilização do rimonabante para o preparo de medicamentos úteis na prevenção e no tratamento do diabetes do tipo 2 |
EP06709344A EP1853264A1 (fr) | 2005-02-21 | 2006-02-20 | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
KR1020077018993A KR20070104913A (ko) | 2005-02-21 | 2006-02-20 | 2형 당뇨병의 예방 및 치료에 사용될 수 있는 약제의제조를 위한 리모나반트의 용도 |
PCT/FR2006/000376 WO2006087481A1 (fr) | 2005-02-21 | 2006-02-20 | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
CA002597245A CA2597245A1 (fr) | 2005-02-21 | 2006-02-20 | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
TW095105631A TW200640457A (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
JP2007555669A JP2008530189A (ja) | 2005-02-21 | 2006-02-20 | 2型糖尿病の防止および処置において使用することができる医薬品を調製するためのリモナバントの使用 |
UY29386A UY29386A1 (es) | 2005-02-21 | 2006-02-20 | Utilizción de rimonabant para la preparación de medicamentos útiles en la prevención y el tratamiento de la diabetes de tipo2. |
EA200701781A EA011618B1 (ru) | 2005-02-21 | 2006-02-20 | Применение римонабанта для получения лекарственных средств, пригодных для профилактики и лечения диабета типа 2 |
AU2006215444A AU2006215444A1 (en) | 2005-02-21 | 2006-02-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
ARP060100611A AR053812A1 (es) | 2005-02-21 | 2006-02-21 | Utilizacion de rimonabant para la preparacion de medicamentos utiles en la prevencion y el tratamiento de la diabetes de tipo2 |
TNP2007000297A TNSN07297A1 (en) | 2005-02-21 | 2007-07-31 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
US11/832,865 US20080015229A1 (en) | 2005-02-21 | 2007-08-02 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
CR9293A CR9293A (es) | 2005-02-21 | 2007-08-07 | Utilizacion de rimonabant para la preparacion de medicamentos utiles en la prevencion y el tratamiento de la diabetes de tipo 2 |
IL185401A IL185401A0 (en) | 2005-02-21 | 2007-08-20 | Use of rimonabant for the preparation of medicaments that can be used in the prevention and treatment of type 2 diabetes |
MA30158A MA29262B1 (fr) | 2005-02-21 | 2007-08-23 | Utilisation du rimonabant pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
NO20074767A NO20074767L (no) | 2005-02-21 | 2007-09-18 | Anvendelse av rimonabant for fremstilling av medikamenter som kan anvendes i forebygging og behandling av type 2 diabetes |
US12/402,988 US20090197917A1 (en) | 2005-02-21 | 2009-03-12 | Use of rimonabant for the preparation of medicaments useful in the prevention and treatment of type 2 diabetes |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0501861A FR2882261B1 (fr) | 2005-02-21 | 2005-02-21 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
FR0504942A FR2882264A1 (fr) | 2005-02-21 | 2005-05-12 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
FR0505228A FR2882265B1 (fr) | 2005-02-21 | 2005-05-23 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. |
Publications (2)
Publication Number | Publication Date |
---|---|
FR2882265A1 FR2882265A1 (fr) | 2006-08-25 |
FR2882265B1 true FR2882265B1 (fr) | 2009-02-13 |
Family
ID=36809538
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0504942A Withdrawn FR2882264A1 (fr) | 2005-02-21 | 2005-05-12 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
FR0505228A Expired - Fee Related FR2882265B1 (fr) | 2005-02-21 | 2005-05-23 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR0504942A Withdrawn FR2882264A1 (fr) | 2005-02-21 | 2005-05-12 | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 |
Country Status (10)
Country | Link |
---|---|
JP (1) | JP2008530189A (fr) |
BR (1) | BRPI0608183A2 (fr) |
CR (1) | CR9293A (fr) |
EA (1) | EA011618B1 (fr) |
FR (2) | FR2882264A1 (fr) |
IL (1) | IL185401A0 (fr) |
MA (1) | MA29262B1 (fr) |
MX (1) | MX2007009996A (fr) |
TN (1) | TNSN07297A1 (fr) |
TW (1) | TW200640457A (fr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2789079B3 (fr) * | 1999-02-01 | 2001-03-02 | Sanofi Synthelabo | Derive d'acide pyrazolecarboxylique, sa preparation, les compositions pharmaceutiques en contenant |
US20040122033A1 (en) * | 2002-12-10 | 2004-06-24 | Nargund Ravi P. | Combination therapy for the treatment of obesity |
-
2005
- 2005-05-12 FR FR0504942A patent/FR2882264A1/fr not_active Withdrawn
- 2005-05-23 FR FR0505228A patent/FR2882265B1/fr not_active Expired - Fee Related
-
2006
- 2006-02-20 JP JP2007555669A patent/JP2008530189A/ja not_active Withdrawn
- 2006-02-20 EA EA200701781A patent/EA011618B1/ru not_active IP Right Cessation
- 2006-02-20 MX MX2007009996A patent/MX2007009996A/es not_active Application Discontinuation
- 2006-02-20 BR BRPI0608183-5A patent/BRPI0608183A2/pt not_active IP Right Cessation
- 2006-02-20 TW TW095105631A patent/TW200640457A/zh unknown
-
2007
- 2007-07-31 TN TNP2007000297A patent/TNSN07297A1/en unknown
- 2007-08-07 CR CR9293A patent/CR9293A/es unknown
- 2007-08-20 IL IL185401A patent/IL185401A0/en unknown
- 2007-08-23 MA MA30158A patent/MA29262B1/fr unknown
Also Published As
Publication number | Publication date |
---|---|
TW200640457A (en) | 2006-12-01 |
EA200701781A1 (ru) | 2007-12-28 |
IL185401A0 (en) | 2008-08-07 |
FR2882264A1 (fr) | 2006-08-25 |
EA011618B1 (ru) | 2009-04-28 |
BRPI0608183A2 (pt) | 2009-11-17 |
JP2008530189A (ja) | 2008-08-07 |
FR2882265A1 (fr) | 2006-08-25 |
MX2007009996A (es) | 2007-10-10 |
MA29262B1 (fr) | 2008-02-01 |
CR9293A (es) | 2007-10-01 |
TNSN07297A1 (en) | 2008-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FR2867778B1 (fr) | Utilisation de derives d'indazolecarboxamides pour la preparation d'un medicament destine au traitement et a la prevention du paludisme | |
FR2869541B1 (fr) | Utilisation d'une composition comprenant du d-mannoheptulose et/ou du perseitol dans le traitement et la prevention des maladies liees a une modification de l'immunite innee | |
CL2007003262A1 (es) | Compuestos derivados de 1,4-benzotiepina-1,1-dioxido; composicion farmaceutica; y su uso para el tratamiento de trastornos del metabolismo de lipidos, hiperlipidemia, resistencia a la insulina, diabetes y trastornos del snc, entre otras enfermedades. | |
IL189500A (en) | 4, 2-Diaminopyrimidines are preserved in position 5, containing pharmaceutical preparations and using them to prepare a drug for the treatment of 3x2p receptor mediated diseases and 2/3 x2p | |
MA25820A1 (fr) | Combinaisons d'inhibiteurs de peptidase iv de dipeptidyle et d'autres agents antidiabetiques pour le traitement du mellitus de diabete. | |
CL2007001724A1 (es) | Uso de un estrogeno para el tratamiento de enfermedades, condiciones o sintomas asociados con niveles deficientes de estrogenos en una mujer; composicion farmaceutica que comprende unidades de dosificacion diarias de hemidrato de estradiol > 0,75 y 1 | |
FR2854074B1 (fr) | Utilisation de l'ivermectine pour le traitement de desordres dermatologiques | |
FR2886851B1 (fr) | Composition a base d'une avermectine et de metronidazole notamment pour le traitement de la rosacee | |
FR2900053B1 (fr) | Utilisation du safranal, de la crocine, de la picrocrocine et leurs derives en tant qu'agent de satiete pour le traitement de la surcharge ponderale | |
CL2007003038A1 (es) | Compuestos derivados de 2-fenil-6-aminocarbonil-pirimidina; composicion farmaceutica; y uso en el tratamiento de trastornos vasculares oclusivos. | |
FR2902010B1 (fr) | Utilisation de la 1,7 dimethylxanthine pour la fabrication d'un medicament psychoanaleptique non anxiogene destine au traitement d'un trouble neuropsychiatrique | |
MA28844B1 (fr) | Composition pharmaceutique comprenant de la drospirenone et de l'ethynylestradiol | |
FR2917622B1 (fr) | Utilisation d'un antagoniste par1 dans le traitement de la fibrillation atriale. | |
DE602006002608D1 (de) | 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit | |
FR2919187B1 (fr) | Utilisation d'ecorces de levure pour le traitement et/ou la prevention de l'hyperinsulinemie. | |
HK1097762A1 (en) | Pharmaceutical compositions for the treatment of renal dysfunction, disease or disorder, in particular in diabetic patients | |
CL2004001068A1 (es) | Compuestos derivados de 2,3,4,5-tetrahidrobenzo[f][1,4]oxazepina; procedimientos de preparacion; composicion farmaceutica que los contiene y su uso en la elaboracion de un medicamento util para el tratamiento de la enfermedad de alzheimer. | |
FR2886852B1 (fr) | Composition a base d'une avermectine et d'hydrocortisone notamment pour le traitement de la rosacee | |
FR2882261B1 (fr) | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2 | |
FR2882265B1 (fr) | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du diabete du type 2. | |
ITRM20040223A1 (it) | Medicamento per il trattamento delle infezioni fungine, in particolare dell'aspergillosi. | |
FR2882263B1 (fr) | Utilisation d'un derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement des maladies renales | |
FR2861301B1 (fr) | Utilisation du derive du pyrazole pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique. | |
FR2906469B1 (fr) | Utilisation de composes de la famille des avermectines pour le traitement de desordres dermatologiques chez l'homme | |
FR2913312B1 (fr) | Dispositif d'embrochage de piquets de section meplate dans des ingredients pour la realisation de brochettes. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
ST | Notification of lapse |
Effective date: 20110131 |